ir.athersys.com

Athersys - Who We Are

Congestive Heart Failure (CHF). Athersys to Present at Needham Healthcare Conference on March 28. CLEVELAND, March 20, 2018 (GLOBE NEWSWIRE) - Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City. The presentation is scheduled . Athersys Reports Financial Results for Fourth Quarter, Full Year 2017. Athersys is a clinical-stage biotechnology...

http://ir.athersys.com/

OVERVIEW OF ir.athersys.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IR.ATHERSYS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 7 reviews

5 star

1

4 star

5

3 star

1

2 star

0

1 star

0

Hey there! Start your review of ir.athersys.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.5 seconds

FAVICON PREVIEW

16x16

CONTACTS AT IR.ATHERSYS.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

20

SSL

EXTERNAL LINKS

2

SITE IP

206.200.251.19

LOAD TIME

0.546 sec

SCORE

6.2

PAGE TITLE

Athersys - Who We Are | ir.athersys.com Reviews

<META> DESCRIPTION

Congestive Heart Failure (CHF). Athersys to Present at Needham Healthcare Conference on March 28. CLEVELAND, March 20, 2018 (GLOBE NEWSWIRE) - Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City. The presentation is scheduled . Athersys Reports Financial Results for Fourth Quarter, Full Year 2017. Athersys is a clinical-stage biotechnology...

<META> KEYWORDS

1 careers

2 about us

3 business strategy

4 management

5 board of directors

6 committee composition

7 contact the board

8 multistem programs

9 multistem overview

10 neurological

CONTENT

Page content here

KEYWORDS ON PAGE

careers,about us,business strategy,management,board of directors,committee composition,contact the board,multistem programs,multistem overview,neurological,ischemic stroke,other neurological indications,cardiovascular,acute myocardial infarction,gvhd,digg

POWERED BY

ASP.NET

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Athersys - Who We Are | ir.athersys.com Reviews

https://ir.athersys.com

Congestive Heart Failure (CHF). Athersys to Present at Needham Healthcare Conference on March 28. CLEVELAND, March 20, 2018 (GLOBE NEWSWIRE) - Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City. The presentation is scheduled . Athersys Reports Financial Results for Fourth Quarter, Full Year 2017. Athersys is a clinical-stage biotechnology...

INTERNAL PAGES

ir.athersys.com

1

Athersys - Ischemic Stroke

http://ir.athersys.com/ischemicStroke.cfm

Congestive Heart Failure (CHF). MultiStem has potential as a “best-in-class” cell therapy based on its ability to deliver therapeutic benefit through multiple mechanisms of action, its ability to be delivered “off-the-shelf” like a pharmaceutical product and its consistent safety profile. MultiStem appears capable of delivering a therapeutic benefit in multiple ways, such as through the production of factors that:. Protect damaged or injured neurons. Reduce inflammation common in ischemic injury.

2

Athersys to Host Second Quarter Financial Results Call (NASDAQ:ATHX)

http://ir.athersys.com/releasedetail.cfm?ReleaseID=922042

Laquo; Previous Release. Next Release ». Back to main Press Release page. July 14, 2015. Athersys to Host Second Quarter Financial Results Call. July 14, 2015. Nasdaq:ATHX) will release its second quarter 2015 financial results at approximately. 4:00 PM EDT on Thursday. August 6, 2015. And host a conference call shortly thereafter at. To review the results. Chairman and Chief Executive Officer, and William (. President and Chief Operating Officer, will host the call as follows:. August 6, 2015. Has forge...

3

Athersys - Other Programs

http://ir.athersys.com/msOtherPrograms.cfm

Congestive Heart Failure (CHF). We are actively exploring the potential for applying MultiStem across a range of disease areas. Potential areas of application include the treatment of blood and immune system disorders, autoimmune disease, orthopedic indications, and other areas. Congestive Heart Failure (CHF). Committed to helping stroke patients. Developing safer and more effective therapeutic products.

4

Athersys - Business Strategy

http://ir.athersys.com/businessStrategy.cfm

Congestive Heart Failure (CHF). Our business strategy is to:. Develop a portfolio of therapeutic products and programs in a highly cost effective manner (as opposed to developing a single opportunity);. Develop “best-in-class products” that have the potential to be safer and more effective than current standard of care, and that can address substantial unmet medical needs (as opposed to developing “me too” products);. We are developing the MultiStem. Our business strategy is to:. Develop a portfolio of t...

5

Athersys - Inflammatory and Immune

http://ir.athersys.com/inflammatoryImmune.cfm

Congestive Heart Failure (CHF). Congestive Heart Failure (CHF). Committed to helping stroke patients. Developing safer and more effective therapeutic products. We are committed to developing safer and more effective therapeutic products that we believe represent substantial improvements over existing therapies, and that will create significant value for our shareholders.

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

SOCIAL ENGAGEMENT

share.php

athersys

OTHER SITES

ir.associatedestates.com

Associated Estates Realty Corp - Investor Relations

Aug 6, 2015. AEC is dual listed and trades on NASDAQ. Quotes delayed at least 20 minutes. Information provided by eSignal. Wells Fargo Shareowner Services. 1110 Centre Pointe Curve Suite 101. Mendota Heights, MN 55120-4100. The above transfer agent contact information is intended for individual investors who are interested in enrolling in our Dividend Reinvestment Plan in order to buy, sell or transfer AEC stock.

ir.assurant.com

Assurant - Investor Relations

Mobile Device Protection and Support. Consumer Goods Protection and Support. Prearranged Funeral and Final Expenses. We're problem solvers and pioneers. Mobile Device Protection and support. Protecting 34 million mobile devices worldwide, Assurant helps families and friends stay connected. Consumer Goods Protection and Support. We specialize in delivering extended protection programs and support services that strengthen customer loyalty, deliver a memorable experience and generate sustainable profit.

ir.astoriafederal.com

Investor Relations Corporate Overview | Astoria

Astoria Financial Corporation at the Jefferies 2015 Financial Services 1x1 Conference. Tuesday, August 11, 2015. Days before the event. Enter your E-Mail address . Astoria Financial Corporation To Participate In The Jefferies 2015 Financial Services 1x1 Conference. Astoria Bank Kicks Off 16th Annual Kids Tools for School Drive. Astoria Financial Corporation Names Robert Giambrone To Its Board Of Directors. Astoria Financial Corporation Reports 2015 Second Quarter Earnings Per Common Share Of $0.29.

ir.at-global.com

IR情報｜アライドテレシスホールディングス株式会社

Allied Telesis Holdings K.K.

ir.at.st

ir.athersys.com

Athersys - Who We Are

Congestive Heart Failure (CHF). Athersys to Present at Needham Healthcare Conference on March 28. CLEVELAND, March 20, 2018 (GLOBE NEWSWIRE) - Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City. The presentation is scheduled . Athersys Reports Financial Results for Fourth Quarter, Full Year 2017. Athersys is a clinical-stage biotechnology...

ir.atimetals.com

Allegheny Technologies - Investor Relations - Investor Relations Home

The Investor Relations section provides information to current and potential stockholders, securities analysts, and anyone who is interested in the financial and operating performance of the company. This section contains a look at the company's financial performance through earnings reports, stock price and charts, annual report highlights, and Allegheny Technologies filings with the Securities and Exchange Commission. 160; 0.59. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay.

ir.atmel.com

Atmel Corporation - Investors

简体中文 - Chinese (Simplified). Português (Brasil) - Portuguese (Brazil). AVR 8- and 32-bit MCUs. Buttons, Sliders and Wheels. Programmable Logic – SPLD/CPLD. Field Programmable Gate Array. Raquo; Parametric Product Selector. Infotainment / HMI / Connectivity. Safety Critical Touch Interfaces. PLC and I/O Modules. TV High Voltage Edge-Lit. Gas and Water Meters. MCU Software Library - ASF. Atmel Gallery (app store). Third-Party Support - AVR. Third-Party Support - ARM. Atmel Gallery (app store). Aug 3, 2015.

ir.atmgrupa.pl

Komunikaty biznesowe | Relacje inwestorskie | ATM Grupa S.A.

ATM Grupa S.A. Podstawowe dokumenty spółki. Notowania akcji, wykresy. Historia Operacji na Akcjach. Kontakt dla Inwestorów. 3 821,000 zł. Znaczący wzrost przychodów po III kwartałach 2014 r. Kontakt dla inwestorów. Tel: 48 071 77 64 710. Fax: 48 071 77 64 701. Http:/ www.atmgrupa.pl. Publikacja Skonsolidowanego Raportu za I półrocze 2015 r. Publikacja Skonsolidowanego Raportu Kwartalnego za III kw. 2015 r. Raport bieżący nr 10/2015:. Zawarcie umowy znaczącej z Telewizją Polsat Sp. z o.o.

ir.atni.com

Investor Relations : ATN

Skip to main content. Mar 20, 2018. ATN International to Speak at Sidoti and Company Spring 2018 Conference in NYC. Mar 12, 2018. ATN Board Declares Quarterly Dividend. View all press releases. Mar 29, 2018. ATN International to Speak at Sidoti and Company Spring 2018 Conference. Mar 5, 2018. Raymond James Investor Conference March 2018. View all events and presentations. 2017 Annual Letter to Stockholders. File is in Briefcase. View all Financials and Filings. Click here to Contact Us. Day Low: 59.25.

ir.atossagenetics.com

Atossa Genetics, Inc. (ATOS)

Atossa Genetics, Inc., The Breast Health Company™, based in Seattle, WA, is focused on improving breast health through the commercialization of patented medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc. (NRLBH), patented tests. The NRLBH is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, Washington. Aug 6, 2015. Jun 30, 2015. Sign up for email alerts. Be the first to receive breaking news. Mr Youmans br...